The Story of Pharma Bro Martin Shkreli: Business Case Study Explained
Martin Shkreli is a former hedge fund manager and pharmaceutical executive who gained notoriety for his controversial business practices and public persona. He now has a youtube channel called @TheShkreliPill and @realmartinshkreli where streams commentary on finance and has even commentated on Sam Bankman Fried and the FTX story and other major financial and political stories. He also appeared My First Million where he goes into detail about what he did, why he did it, and of course, how much money he made doing it.
Martin Shkreli Reveals How He Made His First $100 Million
Shkreli first gained widespread attention in 2015, when his company Turing Pharmaceuticals raised the price of Daraprim, a drug used to treat parasitic infections in HIV patients, from $13.50 per pill to $750 per pill. This 5,000% price hike sparked outrage and scrutiny, leading to congressional hearings and a public backlash against Shkreli.
Shkreli was also the founder and CEO of Retrophin, a pharmaceutical company that he used to allegedly defraud investors and illegally manipulate the stock price. In 2017, he was convicted of securities fraud and sentenced to seven years in prison.
Shkreli's personal life and behavior also attracted attention, as he frequently made provocative and controversial statements on social media and in interviews. He was known for his brash personality and aggressive tactics in business, earning him the nickname "Pharma Bro."
Overall, Shkreli's actions have been widely criticized for their ethical and moral implications in the pharmaceutical industry and beyond.